Early and Late Phase Research
Venn Life Sciences is a European Contract Research Organisation providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology, medical device and academic organisations. Venn as it is today was founded in 2007, however our history dates back to 1989 when our first offices opened in Paris, France. Since then, Venn has grown to have offices across the Netherlands, Germany, the UK, Ireland and the US.
We have teams across both early and late phase research. Our late phase teams specialise in multi-site cross cultural clinical trials with unique knowledge of local and EU regulations. Over our 25 year history we have built up substantial therapeutic and study experience, contributing to the efficient management of sites, budgets and communication channels with all parties involved. Venn is renowned for its hands-on approach and consistent delivery of high quality work on time and on budget.
In 2015, Venn acquired Kinesis-Pharma adding a dynamic and highly experienced early phase team to our already growing organisation. Our early phase drug development team is based in the Netherlands, consulting with global clients across service areas such as CMC, Pharmacology, Drug Candidate Selection, Pharmacokinetics and much more.
If you would like to know more about our organisation or meet your local contact please click on our contact page for more details on our office locations and contact details – Venn Contact Us.